BCL2 and glioblastoma: Up-regulation of miR-519a expression was found to increase glioblastoma cell sensitivity towards temozolomide—an effect achieved through promoting autophagy via dissociation of Bcl-2/BECN1 complex as well as inhibiting STAT3/Bcl-2 axis activity (64).